Filing Flows

Filing Flows › SkinHealth Systems (SKIN) › Q3 2026 › vs Q3 2025

SkinHealth Systems (SKIN) Q3 2026 vs Q3 2025 (year over year)

SkinHealth Systems's revenue fell $1.5M (-2%) from $70.7M in Q3 2025 to $69.2M in Q3 2026. The biggest changes: Delivery Systems −$2.1M (-10%); Consumables +$575K (+1%).

SkinHealth Systems, Q3 2026: revenue $69.2M (-2% year over year), operating margin 7.2%, net loss $888K, operating cash flow $11.3M. The chart draws each line against Q3 2025, the increases inside each band.

SkinHealth Systems: what changed, Q3 2026 vs Q3 2025SkinHealth Systems: what changed, Q3 2026 vs Q3 2025Operating costs−$12.7MCosts & expenses−$11.6MNet loss−$10.1MNet loss absorbed−$10.1MGeneral & admin−$8.8MOperating cash sources−$8.5MWorking capital & other−$4.2MDepreciation & amortization−$3.3MCost of revenue−$3.0MDelivery Systems−$2.1M

Margins

Q3 2026Q3 2025Change
Free cash flow margin16.1%13.6%+2.5 pts

Every line

LineQ3 2026Q3 2025Change%
Consumables$50.4M$49.8M$575K+1%
Delivery Systems$18.8M$20.8M−$2.1M-10%
Revenue$69.2M$70.7M−$1.5M-2%
Net loss$888K$11.0M−$10.1M-92%
Costs & expenses$70.1M$81.7M−$11.6M-14%
Operating costs$64.2M$76.9M−$12.7M-17%
Interest & other, net$5.1M$4.4M$683K+16%
Income tax$780K$386K$394K+102%
Cost of revenue$22.0M$25.0M−$3.0M-12%
Research & development$1.7M$1.7M−$36K-2%
Sales & marketing$20.0M$20.9M−$920K-4%
General & admin$20.5M$29.2M−$8.8M-30%
Operating cash sources$12.2M$20.7M−$8.5M-41%
Depreciation & amortization$4.0M$7.3M−$3.3M-45%
Share-based compensation$1.4M$2.5M−$1.0M-41%
Working capital & other$6.7M$10.9M−$4.2M-39%
Net loss absorbed$888K$11.0M−$10.1M-92%
Operating cash flow$11.3M$9.6M$1.6M+17%
Free cash flow (OCF − capex)$11.2M$9.6M$1.6M+16%
Capital expenditures$93K$27K$66K+244%

Questions

How much did SkinHealth Systems's revenue grow year over year in Q3 2026?

SkinHealth Systems's revenue fell $1.5M (-2%) from $70.7M in Q3 2025 to $69.2M in Q3 2026.

What drove SkinHealth Systems's revenue change in Q3 2026?

Delivery Systems −$2.1M (-10%); Consumables +$575K (+1%).

Q3 2026 results → · Compare in the interactive Sankey →